In situ vaccination and gene-mediated PD-L1 blockade for enhanced tumor immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In situ vaccination and gene-mediated PD-L1 blockade for enhanced tumor immunotherapy

Published:2021-05 Issue:5 Volume:32 Page:1770-1774
ISSN:1001-8417
Container-title:Chinese Chemical Letters
language:en
Short-container-title:Chinese Chemical Letters

Author:

Hu Yingying,Lin Lin,Guo Zhaopei,Chen Jie,Maruyama Atsushi,Tian Huayu,Chen Xuesi

Funder

the National Natural Science Foundation of China

Jilin province science and technology development program

National Science and Technology Major Projects for Major New Drugs Innovation and Development

Publisher

Elsevier BV

Subject

General Chemistry

Reference39 articles.

1. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

2. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

3. Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy

4. Combination cancer immunotherapy and new immunomodulatory targets

5. PD-1 and Its Ligands in Tolerance and Immunity

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GSH-responsive polymeric micelles-based augmented photoimmunotherapy synergized with PD-1 blockade for eliciting robust antitumor immunity against colon tumor;Journal of Nanobiotechnology;2024-09-05

2. A biomimetic spore nanoplatform for boosting chemodynamic therapy and bacteria-mediated antitumor immunity for synergistic cancer treatment;Asian Journal of Pharmaceutical Sciences;2024-06

3. Exploring the current potential of immunotherapeutic-based treatment approaches for the management of oral cancer: An updated review;Oral Oncology Reports;2024-06

4. Tumor-responsive covalent organic polymeric nanoparticles enhancing STING activation for cancer immunotherapy;Chinese Chemical Letters;2024-04

5. Recent progress of vaccines administration via microneedles for cancer immunotherapy;Chinese Chemical Letters;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3